Abivax Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 7.11 M | $959.03 M | 0.00% | 11.22% |
| UBS GROUP AG | 01/29/2026 | 4.42 M | $596.59 M | -0.84% | 6.98% |
| DARWIN GLOBAL MANAGEMENT, LTD. | 02/17/2026 | 3.18 M | $439.71 M | 0.44% | 5.01% |
| MORGAN STANLEY | 02/13/2026 | 3.15 M | $425.06 M | 114.32% | 4.97% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.41 M | $324.89 M | -17.65% | 3.80% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 1.90 M | $256.22 M | 90.00% | 3.00% |
| CALIGAN PARTNERS LP | 02/17/2026 | 1.45 M | $195.80 M | 0.00% | 2.29% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 1.42 M | $191.15 M | -9.38% | 2.24% |
| FMR LLC | 02/17/2026 | 1.37 M | $184.17 M | -4.54% | 2.15% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 1.35 M | $182.05 M | -30.77% | 2.13% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 1.32 M | $177.65 M | -2.48% | 2.08% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2026 | 1.01 M | $136.20 M | 100.00% | 1.59% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 875.80 K | $118.11 M | 0.00% | 1.38% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 849.73 K | $114.59 M | 152.37% | 1.34% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 764.90 K | $103.15 M | 100.00% | 1.21% |
| OCTAGON CAPITAL ADVISORS LP | 02/17/2026 | 756.00 K | $101.95 M | -42.94% | 1.19% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 754.84 K | $101.79 M | 2,080.72% | 1.19% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 741.06 K | $99.94 M | -32.63% | 1.17% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/11/2026 | 691.97 K | $93.32 M | -5.41% | 1.09% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 667.76 K | $90.04 M | 88.24% | 1.05% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 657.83 K | $88.71 M | 54.24% | 1.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 651.64 K | $87.88 M | 35.80% | 1.03% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 649.18 K | $87.55 M | -18.98% | 1.02% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 600.75 K | $81.01 M | 166.46% | 0.95% |
| CITADEL ADVISORS LLC | 02/17/2026 | 563.75 K | $76.02 M | -17.31% | 0.89% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 550.00 K | $74.17 M | -43.74% | 0.87% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 522.29 K | $70.43 M | 446.37% | 0.82% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 518.35 K | $69.90 M | 13.75% | 0.82% |
| BVF INC/IL | 02/17/2026 | 508.03 K | $68.51 M | -8.96% | 0.80% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 507.88 K | $68.49 M | -15.06% | 0.80% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 505.00 K | $68.10 M | 40.28% | 0.80% |
| BARCLAYS PLC | 02/13/2026 | 500.00 K | $67.43 M | 100.00% | 0.79% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 500.00 K | $67.43 M | 100.00% | 0.79% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 458.34 K | $61.81 M | 17.94% | 0.72% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 457.33 K | $61.67 M | 0.00% | 0.72% |
| JPMORGAN CHASE & CO | 02/11/2026 | 455.92 K | $61.48 M | 100.00% | 0.72% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 449.12 K | $60.57 M | -12.98% | 0.71% |
| BLACKROCK, INC. | 02/12/2026 | 436.71 K | $58.89 M | 100.00% | 0.69% |
| ABRDN PLC | 01/16/2026 | 426.66 K | $57.54 M | -45.82% | 0.67% |
| JANE STREET GROUP, LLC | 02/12/2026 | 423.26 K | $57.08 M | 524.25% | 0.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 422.19 K | $56.93 M | -21.77% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 409.00 K | $55.16 M | 804.87% | 0.65% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 400.00 K | $53.94 M | -3.61% | 0.63% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 391.78 K | $52.83 M | 135.63% | 0.62% |
| FARALLON CAPITAL MANAGEMENT LLC | 02/17/2026 | 387.00 K | $52.19 M | -51.93% | 0.61% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 381.23 K | $51.41 M | 30.64% | 0.60% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 378.30 K | $51.02 M | 0.00% | 0.60% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 367.90 K | $49.61 M | -3.18% | 0.58% |
| VIVO CAPITAL, LLC | 02/13/2026 | 359.31 K | $48.45 M | 0.00% | 0.57% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 358.32 K | $48.32 M | 123.64% | 0.57% |
Abivax institutional Ownership - FAQ's
During the previous two years, 266 institutional investors and hedge funds held shares of Abivax. The most heavily invested institutionals were:
TCG Crossover Management, LLC: 7.11 M
UBS Group AG: 4.42 M
Darwin Global Management, Ltd.: 3.18 M
MORGAN STANLEY: 3.15 M
Point72 Asset Management, L.P.: 2.41 M
Vestal Point Capital, LP: 1.9 M
88.80% of Abivax stock is owned by institutional investors.
Institutional investors have bought a total of 56.17 M shares in the last 24 months. This purchase volume represents approximately $6.16 B in transactions.